The U.S. Food and Drug Administration (FDA) has accepted Sentynl Therapeutics Inc.’s New Drug Application (NDA) for CUTX-101 ...
“Today marks a significant milestone in Halia’s journey,” said Dr. David J. Bearss, President & CEO of Halia Therapeutics.
Gaelic Laboratories, a European CMO based in Ireland, has established a subsidiary in the UAE, enabling access to the Middle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback